Disc Medicine: A Bitopertin Requiem

The price used for valuation, according to the paperwork, was $64.51 per share. A number, really, like any other. It just happened to represent a tiny slice of ownership in a company trying to make people less sensitive to sunlight. A noble goal, I suppose.







